Skip to main content
Premium Trial:

Request an Annual Quote

Yourgene Inks US Distribution Deal for Chemotoxicity Assay, Other Tests

NEW YORK — UK-based molecular diagnostics firm Yourgene Health said on Monday that it has signed on Immuno-Biological Laboratories (IBL-America) as a nonexclusive US distributor of its Elucigene DPYD chemotoxicity assay and certain other reproductive health tests.

Under the terms of the deal, Spring Lake Park, Minnesota-based IBL-America will distribute in the US Elucigene DPYD, which identifies cancer patients with an enzyme deficiency that can result in serious side effects from 5-fluorouracil treatment, as well as Yourgene's PCR-based tests for cystic fibrosis, male factor infertility, and invasive aneuploidy.

Yourgene said the tests will initially be sold by IBL-America for research use only to research groups and CLIA labs for in-house validation prior to clinical use. Yourgene said that it may pursue FDA registration of the tests depending on customer demand.

Additional terms of the deal were not disclosed.

"The appointment of IBL-America is an important pillar within our plans to penetrate the largest diagnostics market in the world with our full portfolio across the whole genomic testing lifecycle," Yourgene CEO Lyn Rees said in a statement.

In August, Yourgene agreed to acquire Canadian sample prep technology firm Coastal Genomics for up to $13.5 million. 

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.